DE60333902D1 - Antidepressivum - Google Patents
AntidepressivumInfo
- Publication number
- DE60333902D1 DE60333902D1 DE60333902T DE60333902T DE60333902D1 DE 60333902 D1 DE60333902 D1 DE 60333902D1 DE 60333902 T DE60333902 T DE 60333902T DE 60333902 T DE60333902 T DE 60333902T DE 60333902 D1 DE60333902 D1 DE 60333902D1
- Authority
- DE
- Germany
- Prior art keywords
- gen
- acyl
- substituted
- benzofused
- protein kinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Furan Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002055771 | 2002-03-01 | ||
JP2002195434 | 2002-07-04 | ||
PCT/JP2003/002293 WO2003074046A1 (fr) | 2002-03-01 | 2003-02-28 | Antidepresseur |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60333902D1 true DE60333902D1 (de) | 2010-10-07 |
Family
ID=27790932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60333902T Expired - Lifetime DE60333902D1 (de) | 2002-03-01 | 2003-02-28 | Antidepressivum |
Country Status (13)
Country | Link |
---|---|
US (2) | US20050148650A1 (de) |
EP (1) | EP1481679B1 (de) |
JP (1) | JP2010111698A (de) |
KR (1) | KR101011657B1 (de) |
CN (1) | CN1638763A (de) |
AT (1) | ATE478666T1 (de) |
AU (1) | AU2003211261A1 (de) |
CA (1) | CA2477903C (de) |
DE (1) | DE60333902D1 (de) |
HK (1) | HK1070273A1 (de) |
NO (1) | NO20043786L (de) |
PL (1) | PL371366A1 (de) |
WO (1) | WO2003074046A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004082517A2 (en) * | 2003-03-19 | 2004-09-30 | Bar Ilan University | Animal exhibiting ptsd-like behavior, per pct rule 4.3 |
CL2007003217A1 (es) * | 2006-11-09 | 2008-07-04 | Takeda Pharmaceutical | Composicion farmaceutica que comprende 1) (r)-5,6-dimetoxi-2-[2,2,4,6,7-pentametil-3-(4-metil-fenil)-2,3-dihidro-1-benzofuran-5-il]-isoindolina, 2) un componente lipofilico y 3) un agente tensoactivo; y capsula que contiene a dicha composicion farmac |
JP5524083B2 (ja) | 2008-01-30 | 2014-06-18 | セファロン、インク. | ヒスタミン−3(h3)受容体リガンドとしての置換スピロ環状ピペリジン誘導体 |
TWI477497B (zh) * | 2009-03-10 | 2015-03-21 | Takeda Pharmaceutical | 苯并呋喃衍生物 |
US8828924B2 (en) * | 2009-05-14 | 2014-09-09 | University Of Maryland, Baltimore | Methods of treating a diabetic embryopathy |
WO2013035826A1 (ja) * | 2011-09-08 | 2013-03-14 | 武田薬品工業株式会社 | 縮合複素環化合物 |
JP2017527559A (ja) | 2014-08-29 | 2017-09-21 | シーエイチディーアイ ファウンデーション,インコーポレーテッド | ハンチントンタンパク質のイメージング用プローブ |
CA3058048A1 (en) * | 2017-03-24 | 2018-09-27 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical composition for the treatment of neurodegenerative disease |
IL309666A (en) | 2021-07-09 | 2024-02-01 | Plexium Inc | Aryl compounds and pharmaceutical preparations that modulate IKZF2 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4799934A (en) | 1987-10-30 | 1989-01-24 | Clairol Incorporated | Sulfur-containing nitroaminobenzene dyes, process and hair dye compositions |
EP0539709A1 (de) * | 1991-09-18 | 1993-05-05 | FUJIREBIO Inc. | 3,5-Dihydroxyheptansäurederivate und deren Lactone als HMG-CoA-Reduktase-Inhibitoren |
ATE218583T1 (de) | 1995-03-14 | 2002-06-15 | Praecis Pharm Inc | Verbindungen mit aggregations-modulierenden wirkung auf das amyloid protein |
EP1586584A1 (de) | 1996-08-27 | 2005-10-19 | Praecis Pharmaceuticals Incorporated | beta-Amyloid Peptidaggregation regulierende Peptide mit D-Aminosäuren |
JPH1149765A (ja) * | 1997-06-05 | 1999-02-23 | Takeda Chem Ind Ltd | 複素環化合物、その製造法および剤 |
WO1998055454A2 (en) * | 1997-06-05 | 1998-12-10 | Takeda Chemical Industries, Ltd. | Benzofurans and benzothophenes as suppressors of neurodegeneration |
ES2234300T3 (es) | 1998-10-08 | 2005-06-16 | Smithkline Beecham Plc | 3-(3-cloro-4-hidroxifenilamino)-4-(2-nitrofenil)-1h-pirrol-2,5-diona como inhibidor de glucogeno cinasa-3 (gsk-3)sintetasa. |
KR100660788B1 (ko) * | 1998-12-04 | 2007-02-28 | 다케다 야쿠힌 고교 가부시키가이샤 | 벤조푸란 유도체, 그 제조법 및 용도 |
US6545127B1 (en) | 1999-06-28 | 2003-04-08 | Oklahoma Medical Research Foundation | Catalytically active recombinant memapsin and methods of use thereof |
JP2002201172A (ja) * | 2000-02-25 | 2002-07-16 | Japan Tobacco Inc | ベンズアミド誘導体及びその用途 |
WO2001068666A1 (en) * | 2000-03-14 | 2001-09-20 | Thomas Jefferson University | Tcl1 enhances akt kinase activity and mediates its nuclear translocation |
GB0022333D0 (en) | 2000-09-12 | 2000-10-25 | Glaxo Group Ltd | Methods for identifying modulators of protein interactions |
JP2002348239A (ja) | 2000-10-05 | 2002-12-04 | Takeda Chem Ind Ltd | 幹細胞・神経前駆細胞の増殖・分化促進剤 |
DE60137437D1 (de) * | 2000-10-05 | 2009-03-05 | Takeda Pharmaceutical | Promotoren zur proliferation und differenzierung von stammzellen und/oder vorstufen von neuronenzellen |
CA2432410A1 (en) * | 2000-12-28 | 2002-07-11 | Takeda Chemical Industries, Ltd. | Process for preparing optically active 2,3-dihydro- benzofuran compounds |
US7153871B2 (en) * | 2001-01-22 | 2006-12-26 | Memory Pharmaceuticals Corporation | Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
US6566550B2 (en) * | 2001-06-21 | 2003-05-20 | Pfizer Inc | Substituted aromatic ethers as inhibitors of glycine transport |
WO2003004485A1 (en) * | 2001-07-05 | 2003-01-16 | Takeda Chemical Industries, Ltd. | Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof |
-
2003
- 2003-02-28 PL PL03371366A patent/PL371366A1/xx not_active Application Discontinuation
- 2003-02-28 EP EP03707169A patent/EP1481679B1/de not_active Expired - Lifetime
- 2003-02-28 KR KR1020047013566A patent/KR101011657B1/ko not_active IP Right Cessation
- 2003-02-28 AT AT03707169T patent/ATE478666T1/de not_active IP Right Cessation
- 2003-02-28 US US10/506,269 patent/US20050148650A1/en not_active Abandoned
- 2003-02-28 DE DE60333902T patent/DE60333902D1/de not_active Expired - Lifetime
- 2003-02-28 WO PCT/JP2003/002293 patent/WO2003074046A1/ja active Application Filing
- 2003-02-28 CA CA2477903A patent/CA2477903C/en not_active Expired - Fee Related
- 2003-02-28 AU AU2003211261A patent/AU2003211261A1/en not_active Abandoned
- 2003-02-28 CN CNA038048728A patent/CN1638763A/zh active Pending
-
2004
- 2004-09-09 NO NO20043786A patent/NO20043786L/no not_active Application Discontinuation
-
2005
- 2005-04-07 HK HK05102926.0A patent/HK1070273A1/xx not_active IP Right Cessation
-
2006
- 2006-06-27 US US11/475,539 patent/US7750037B2/en not_active Expired - Fee Related
-
2010
- 2010-01-13 JP JP2010005081A patent/JP2010111698A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
NO20043786L (no) | 2004-09-09 |
US20060241168A1 (en) | 2006-10-26 |
ATE478666T1 (de) | 2010-09-15 |
KR20040096636A (ko) | 2004-11-16 |
JP2010111698A (ja) | 2010-05-20 |
HK1070273A1 (en) | 2005-06-17 |
CN1638763A (zh) | 2005-07-13 |
WO2003074046A1 (fr) | 2003-09-12 |
CA2477903C (en) | 2010-10-12 |
US20050148650A1 (en) | 2005-07-07 |
EP1481679B1 (de) | 2010-08-25 |
EP1481679A1 (de) | 2004-12-01 |
CA2477903A1 (en) | 2003-09-12 |
AU2003211261A1 (en) | 2003-09-16 |
KR101011657B1 (ko) | 2011-01-28 |
US7750037B2 (en) | 2010-07-06 |
PL371366A1 (en) | 2005-06-13 |
EP1481679A4 (de) | 2005-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1070273A1 (en) | Antidepressant | |
MY125506A (en) | Benzodiazepine derivatives as metabotropic glutamate receptor antagonists | |
DK1680418T3 (da) | Derivater af N-(heteroaryl-(piperidin-2yl)methyl)benzamid, deres fremstilling og deres anvendelse som terapeutika | |
DE69528257D1 (de) | KONDENSIERTE HETEROCYCLISCHE VERBINDUNG, DEREN HERSTELLUNG UND VERWENDUNG ALS GnRH ANTAGONISTEN | |
EP1312601A4 (de) | Carbonsäurederivate, verfahren zu deren herstellung und medikamente, die diese als wirkstoff enthalten | |
EA200500037A1 (ru) | Фенилбензамиды | |
EP1411052A4 (de) | Benzokondensierte 5gliedrige heterocyclische verbindungen, verfahren zu deren herstellung und deren verwendung | |
WO2003082847A1 (fr) | Derive de benzofurane | |
ATE347356T1 (de) | Hydroxamsäurederivate als antibakterielle arzneimittel | |
TR199900477T2 (xx) | Thiazolil-alanin art��� ihtiva eden yeni peptid t�revleri. | |
UY25636A1 (es) | Proceso para la preparacion de compuestos azopoliciclicos condensados | |
DE69625709D1 (de) | Alpha-substituierte heterozyklische benzylderivate, zwischenverbindungen zu ihrer herstellung und pestizide die diese als aktiver bestandteil enthalten | |
PT1165485E (pt) | Processo para a preparacao de produtos intermediarios pesticidas | |
ATE272048T1 (de) | Aminosäuren mit polycyclischer struktur als pharmaka | |
BR9611572A (pt) | Produção de um sal de ácido clavulânico | |
BR9307232A (pt) | 4-Estrenos ligados por meio de ponte-19,11 com efic cia gestag-nica | |
CY1110613T1 (el) | Υποκατεστημενες θειαζολες και η χρησιμοποιηση τους για την παρασκευη φαρμακων | |
ATE176235T1 (de) | Verwendung von cephem-derivaten als antimetastatische mittel | |
DE69608699T2 (de) | Fluorsubstituierte benzoylpropionsaürederivate | |
AU6595000A (en) | Dihydrobenzofuran derivatives, process for the preparation thereof and agents | |
DE60021109D1 (de) | Amycomycin, verfahren zu dessen herstellung und seine verwendung als arzneimittel | |
ES2150073T3 (es) | Nuevos agentes fungicidas ll-15g256gamma, delta y epsilon, producidos por el ll-15g256 (hypoxylon oceanicum). | |
PT90831A (pt) | Processo para a preparacao de eteres da 2-amino-7-hidroxitetralina | |
TH86640A (th) | สารปรับตัวรับไซยาโนพรัยโรล-ซัลโฟนาไมด์โปรเจสเตอโรนและการใช้สารนี้ |